Correction: Fabrication of novel vildagliptin loaded ZnO nanoparticles for anti diabetic activity(Scientific Reports, 10.1038/s41598-024-67420-z)

Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-67420-z, published online 02 August 2024 The original version of this Article contained errors in the baseline correction of the FT-IR analysis in Figure 6. The original Figure 6 and accompanying legend appear below. (Figure presented.) Vildagliptin-loaded ZnO NPs: FT-IR analysis. In addition, References 4, 6, 13 and 20 were incorrect. The correct References are listed below: 4. Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A. & Prakash, O. A review on diabetes mellitus: type1 & Type2. World J. Pharm. Pharm. Sci.9(10), 838–850 (2020). 6. Swain, R. P., Subudhi, B. B., Mahapatra, A. K. & Bolapareddi, V. Bridging between disease, prevalence and treatment of diabetes mellitus: a review. Int. J. Pharm. Tech. Res.7(2), 212–228 (2015). 13. Singh, P., Kim, Y. J., Zhang, D. & Yang, D. C. Biological synthesis of nanoparticles from plants and microorganisms. Trends Biotechnol.34(7), 588–599 (2016). 20. Broadhurst, C. L. & Domenico, P. Clinical studies on chromium picolinate supplementation in diabetes mellitus—a review. Diabetes Technol. Ther.8(6), 677–687 (2006). The original Article has been corrected.